Science Market Shifts as Novo Nordisk and Eli Lilly Compete in GLP-1 Space Jared Holz, an analyst at Mizuho Securities, provided insights on the competitive landscape of the GLP-1 medication market during a recent appearance on the... Editorial5 hours ago